Brief: Evofem Biosciences Announces Strong Q2 Results And Affirms 2022 Guidance
04/08/2022 21:56
Aug 4 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM BIOSCIENCES ANNOUNCES STRONG SECOND QUARTER 2022 FINANCIAL RESULTS
AND
AFFIRMS 2022 GUIDANCE
* EVOFEM BIOSCIENCES INC - CONTINUES TO EXPECT NET PRODUCT SALES IN RANGE OF
$30
TO $35 MILLION FOR ITS 2022 FISCAL YEAR
* EVOFEM BIOSCIENCES INC - REMAINS ON TRACK TO MEET ITS GOAL OF REDUCING
COSTS BY
$50 MILLION IN 2022
Source text for Eikon: ID:nPn1DjrDsa
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting